Immunophenotyping and leukocyte redistribution in corticosteroid resistant severe asthma
- PMID: 36196589
- DOI: 10.1111/cea.14233
Immunophenotyping and leukocyte redistribution in corticosteroid resistant severe asthma
Comment on
-
Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma.Clin Exp Allergy. 2022 Oct;52(10):1183-1194. doi: 10.1111/cea.14128. Epub 2022 Apr 1. Clin Exp Allergy. 2022. PMID: 35305052 Free PMC article.
References
REFERENCES
-
- Bleecker ER, Menzies-Gow AN, Price DB, et al. Systematic literature review of systemic corticosteroid use for asthma management. Am J Respir Crit Care Med. 2020;201(3):276-293. doi:10.1164/rccm.201904-0903SO
-
- Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2013;131(3):636-645. doi:10.1016/j.jaci.2012.12.1564
-
- Cardoso-Vigueros C, von Blumenthal T, Rückert B, et al. Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma. Clin Exp Allergy. 2022. doi:10.1111/cea.14128
-
- Muehling LM, Heymann PW, Carper H, et al. Cluster analysis of nasal cytokines during rhinovirus infection identifies different immunophenotypes in both children and adults with allergic asthma. Clin Exp Allergy. 2022. doi:10.1111/cea.14176
-
- Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364(11):1005-1015. doi:10.1056/NEJMoa1009705
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
